Direct internalization of cell-surface BST-2/tetherin by the HIV-1 accessory protein Vpu

References

• Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 1992; 66:7193 - 7200
   PubMed Web of Science ®Google Scholar
• Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 1992; 66:226 - 234
   PubMed Web of Science ®Google Scholar
• Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008; 451:425 - 430
   PubMed Web of Science ®Google Scholar
• Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, et al. The interferoninduced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008; 3:245 - 252
   PubMed Web of Science ®Google Scholar
• Fujita K, Omura S, Silver J. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J Gen Virol 1997; 78:619 - 625
   PubMed Web of Science ®Google Scholar
• Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1998; 1:565 - 574
   PubMed Web of Science ®Google Scholar
• Schubert U, Anton LC, Bacik I, Cox JH, Bour S, Bennink JR, et al. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol 1998; 72:2280 - 2288
   PubMed Web of Science ®Google Scholar
• Butticaz C, Michielin O, Wyniger J, Telenti A, Rothenberger S. Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J Virol 2007; 81:1502 - 1505
   PubMed Web of Science ®Google Scholar
• Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, Moses AV. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 2009; 83:7931 - 7947
   PubMed Web of Science ®Google Scholar
• Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, et al. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem 2009; 284:35060 - 35072
   PubMed Web of Science ®Google Scholar
• Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, et al. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via β-TrCP and endo-lysosomal trafficking. PLoS Pathog 2009; 5:1000450
   PubMed Web of Science ®Google Scholar
• Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog 2009; 5:1000574
   PubMed Web of Science ®Google Scholar
• Goffinet C, Allespach I, Homann S, Tervo H-M, Habermann A, Rupp D, et al. HIV-1 Antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 2009; 5:285 - 297
   PubMed Web of Science ®Google Scholar
• Gupta RK, Hue S, Schaller T, Verschoor E, Pillay D, Towers GJ. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog 2009; 5:1000443
   Web of Science ®Google Scholar
• McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, et al. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 2009; 5:1000300
   Web of Science ®Google Scholar
• Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, Aloysius C, et al. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol 2009; 83:7536 - 7546
   PubMed Web of Science ®Google Scholar
• Nichols B. Caveosomes and endocytosis of lipid rafts. J Cell Sci 2003; 116:4707 - 4714
   PubMed Web of Science ®Google Scholar